Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Tag: SOP gap analysis

When Approved SOPs Remain Ineffective: GMP Risks from Missing Effective Dates

Posted on By

When Approved SOPs Remain Ineffective: GMP Risks from Missing Effective Dates The Compliance Risk of Approved SOPs Without Effective Implementation Introduction to the Audit Finding 1. What Was Observed Approved SOPs were not made effective due to missing effective dates or lack of internal communication. As a result, personnel continued using superseded or draft versions…

Read More “When Approved SOPs Remain Ineffective: GMP Risks from Missing Effective Dates” »

GMP Audit Findings, SOP Implementation Gaps

SOP Compliance in Training, Deviations, and Investigations

Posted on By

SOP Compliance in Training, Deviations, and Investigations Ensuring SOP Compliance Through Training, Deviation Control, and Investigations Standard Operating Procedures (SOPs) are the backbone of any pharmaceutical quality system. However, writing SOPs is not enough; their effective implementation across training, deviation management, and investigations determines true compliance. Regulatory authorities including USFDA and EMA stress on demonstrated…

Read More “SOP Compliance in Training, Deviations, and Investigations” »

SOP Compliance Monitoring, SOP Guidelines

Root Cause Analysis of SOP Deviations

Posted on By

Root Cause Analysis of SOP Deviations How to Conduct Effective Root Cause Analysis of SOP Deviations Deviations from Standard Operating Procedures (SOPs) are a common occurrence in pharmaceutical manufacturing, quality control, and operational processes. While deviations themselves are undesirable, the real risk lies in failing to understand and eliminate their root causes. This tutorial explains…

Read More “Root Cause Analysis of SOP Deviations” »

SOP Compliance Monitoring, SOP Guidelines

Internal Audits for SOP Compliance: A Practical Guide

Posted on By

Internal Audits for SOP Compliance: A Practical Guide Conducting Internal Audits for SOP Compliance: Step-by-Step Guidance Internal audits are essential tools in pharmaceutical quality systems to ensure ongoing compliance with SOPs. They help identify procedural gaps, training lapses, and operational non-conformances before regulatory authorities do. A robust internal audit program can transform SOPs from mere…

Read More “Internal Audits for SOP Compliance: A Practical Guide” »

SOP Compliance Monitoring, SOP Guidelines

No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight

Posted on By

No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight GMP Risks of Skipping SOP Assessments After Regulatory Changes Introduction to the Audit Finding 1. Regulatory Changes Are Constant Health authorities worldwide frequently revise GMP standards, including FDA, EMA, WHO, and CDSCO updates. 2. SOPs Must Stay Current Every regulatory update should trigger a…

Read More “No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight” »

GMP Audit Findings, Regulatory Change

GMP Gap: Temporary SOP Changes Not Documented

Posted on By

GMP Gap: Temporary SOP Changes Not Documented Failure to Document Temporary SOP Changes: A Critical GMP Compliance Breakdown Introduction to the Audit Finding 1. Nature of the Finding Temporary changes made to standard procedures were executed during manufacturing or quality operations but not documented formally through the change control system. 2. Why It’s a Compliance…

Read More “GMP Gap: Temporary SOP Changes Not Documented” »

Emergency Changes, GMP Audit Findings

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme